SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Update on the Offer for Subscription

6 Mar 2020 14:57

RNS Number : 3280F
Baronsmead Venture Trust PLC
06 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Venture Trust plc

6 March 2020

Update on the Offer for Subscription

The Board of Baronsmead Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a Prospectus in conjunction with Baronsmead Second Venture Trust plc in relation to an offer for subscription to each raise up to £20 million (before costs) with an over-allotment facility to each raise up to a further £5 million (the "Offer").

On 27 February 2020 the Company carried out a third allotment of shares under the Offer, issuing 6,262,000 new ordinary shares of 10 pence each in the Company ("New Shares"). Subsequently, at the annual general meeting of the Company held on 26 February 2020, shareholders approved the payment of a final dividend of 3.5 pence per share (the "Final Dividend"). However, the net asset value as at 31 January 2020 did not take account of the Final Dividend and accordingly the net asset value used to calculate the issue price which the New Shares were issued at was overstated by the amount of the Final Dividend.

On the basis of the adjusted net asset value the Company has issued an additional 281,420 New Shares resulting in 6,543,420 New Shares being issued in the third allotment under the Offer at an issue price of 80.10 pence.

Applications have been made for the additional New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the additional New Shares to be issued pursuant to the Offer at 8.00 a.m. on 11 March 2020.

Share certificates and tax certificates in respect of the original issue of New Shares have not yet been issued. It is expected that share certificates and tax certificates showing the aggregate number of New Shares issued will be sent to the relevant Shareholders within 10 business days of the date of the allotment of the additional New Shares.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of additional New Shares pursuant to the Offer, the Company will have 249,138,038 Ordinary Shares in issue (of which 20,731,897 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 228,406,141 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFESVEIRIII
Date   Source Headline
1st Jul 20255:17 pmRNSTotal Voting Rights
27th Jun 20255:49 pmRNSTransaction in Own Shares
18th Jun 20255:19 pmRNSDirector/PDMR Shareholding
18th Jun 20254:25 pmRNSAllotment of Shares and Total Voting Rights
17th Jun 20257:00 amRNSChange of Allotment Date
13th Jun 20254:08 pmRNSClose of Offer to New Applications
11th Jun 20257:00 amRNSHalf-year Report
5th Jun 202512:00 pmRNSNet Asset Value(s)
2nd Jun 20252:16 pmRNSTotal Voting Rights
7th May 20253:45 pmRNSNet Asset Value(s)
1st May 202511:10 amRNSAllotment of Shares and Total Voting Rights
29th Apr 20254:15 pmRNSNet Asset Value(s)
25th Apr 202512:04 pmRNSEXTENSION OF THE OFFER
24th Apr 20251:31 pmRNSDirector/PDMR Shareholding
3rd Apr 20252:00 pmRNSAllotment of Shares and Total Voting Rights
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20252:06 pmRNSDirector/PDMR Shareholding
13th Mar 20254:12 pmRNSEXTENSION OF THE OFFER
13th Mar 202511:03 amRNSOver-Allotment Facility and Offer Update
13th Mar 20259:00 amRNSResult of AGM
6th Mar 20253:30 pmRNSNet Asset Value(s)
4th Mar 20255:17 pmRNSTotal Voting Rights
4th Mar 20255:10 pmRNSTransaction in Own Shares
3rd Mar 202511:04 amRNSTotal Voting Rights
26th Feb 20255:30 pmRNSTransaction in Own Shares
24th Feb 20252:02 pmRNSQuarterly Factsheet
20th Feb 20255:18 pmRNSDirector/PDMR Shareholding
20th Feb 20255:16 pmRNSDirector/PDMR Shareholding
20th Feb 20252:30 pmRNSAllotment of Shares and Total Voting Rights
6th Feb 20253:30 pmRNSNet Asset Value(s)
4th Feb 20254:30 pmRNSOffer Update:Close of Early Subscription Incentive
27th Jan 20252:00 pmRNSNet Asset Value(s)
21st Jan 20257:00 amRNSDirectorate Change
10th Jan 202512:15 pmRNSPublication of Prospectus/Offer for subscription
2nd Jan 20257:00 amRNSTotal Voting Rights
24th Dec 20247:00 amRNSAnnual Financial Report
19th Dec 20245:02 pmRNSTransaction in Own Shares
5th Dec 20249:45 amRNSNet Asset Value(s)
2nd Dec 202410:07 amRNSTotal Voting Rights
26th Nov 20242:00 pmRNSUpdate on Offer for Subscription
22nd Nov 20247:00 amRNSCompliance with UK Market Abuse Regulation
18th Nov 20246:18 pmRNSTransaction in Own Shares
8th Nov 202412:30 pmRNSNet Asset Value(s)
31st Oct 202410:00 amRNSNet Asset Value(s)
22nd Oct 20244:29 pmRNSNewsletter H2 2024
1st Oct 20247:00 amRNSIntention to Fundraise
26th Sep 20245:14 pmRNSCORRECTION: Director/PDMR Shareholding
26th Sep 20243:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.